Back

Results - Announcements

Sales decline 4.13% to Rs 237.95 crore

SMS Pharmaceuticals consolidated net profit rises 60.97% in the March 2026 quarter

22-May-2026, 05:30
Net profit of SMS Pharmaceuticals rose 60.97% to Rs 32.71 crore in the quarter ended March 2026 as against Rs 20.32 crore during the previous quarter ended March 2025. Sales declined 4.13% to Rs 237.95 crore in the quarter ended March 2026 as against Rs 248.20 crore during the previous quarter ended March 2025.

For the full year,net profit rose 47.51% to Rs 101.99 crore in the year ended March 2026 as against Rs 69.14 crore during the previous year ended March 2025. Sales rose 13.30% to Rs 886.87 crore in the year ended March 2026 as against Rs 782.75 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	237.95	248.20	-4	886.87	782.75	13
OPM %	16.77	16.44	-	19.31	17.76	-
PBDT	37.20	37.16	0	156.56	126.67	24
PBT	27.07	28.52	-5	116.64	92.34	26
NP	32.71	20.32	61	101.99	69.14	48